Monocyte C1-inhibitor synthesis in patients with C1-inhibitor deficiency

Eur J Clin Invest. 1989 Feb;19(1):45-52. doi: 10.1111/j.1365-2362.1989.tb00194.x.

Abstract

Monocytes of seven out of eight patients with type 1 C1-inhibitor (C1-inh) deficiency (HAE) produced 40% as much C1-inh as monocytes from normal donors (controls). In contrast, monocytes from three patients with type 2 and three patients with acquired C1-inh deficiency produced similar amounts of C1-inh as controls. Recombinant gamma-interferon (gamma-interferon 10 ng/ml) stimulated C1-inh production of C1-inh (eight-10-fold) by control and patients' monocytes. Monocytes from patients with type 1 HAE contained 40% the level of C1-inh messenger ribonucleic acid (mRNA) found in control monocytes. Gamma-interferon increased the abundance of C1-inh mRNA by the same extent in both control and patients' monocytes. C1-inh protein and mRNA were undetectable in the monocytes of one patient, unless stimulated by gamma-interferon. Under these conditions, his monocytes produced comparable amounts of C1-inh (protein and mRNA) as gamma-interferon-stimulated monocytes of the other type 1 HAE patients. The data suggest that in most type 2 HAE patients there is a lesion in the C1-inh gene such that mRNA is transcribed by a single allele.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioedema / genetics
  • Angioedema / immunology*
  • Blotting, Northern
  • Complement C1 Inactivator Proteins / biosynthesis*
  • Complement C1 Inactivator Proteins / deficiency
  • Complement C1 Inactivator Proteins / genetics
  • Complement C2 / biosynthesis
  • Complement C2 / genetics
  • DNA / analysis
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • In Vitro Techniques
  • Monocytes / immunology*
  • RNA, Messenger / analysis

Substances

  • Complement C1 Inactivator Proteins
  • Complement C2
  • RNA, Messenger
  • DNA